Category Archives: 2012

  1. Reformulation of Tenofovir Vaginal Gel Safe for Rectal Use

    via A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests a study published online this week in the Journal of Antimicrobial Chemotherapy. In laboratory tests of rectal tissue, researchers from the Microbicide Trials Network (MTN) found that the reformulated gel Read More >>

    2012, CROI, Microbicide Trials Network, Microbicides, MTN, MTN 007, rectal microbicide, Tenofovir, vaginal microbicide
  2. NYT: Setback on PrEP Results May Have Been Misunderstood

    via The New York Times, by Donald G. McNeil Jr. The failure of a daily pill to protect healthy African women against AIDS may not have been the pill’s fault but the women’s reluctance to take it, scientists at an important AIDS conference in Seattle were told this week. Last April, a promising trial of “pre-exposure prophylaxis” Read More >>

    2012, clinical trials, CROI, pre-exposure prophylaxis, PrEP, Tenofovir, Truvada